TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
Current Value
$80.891 Year Return
Current Value
$80.891 Year Return
Market Cap
$2.78B
P/E Ratio
88.84
1Y Stock Return
22.14%
1Y Revenue Growth
109.09%
Dividend Yield
0.00%
Price to Book
13.3
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DDOG | 56.47% | $45.32B | +19.19% | 0.00% |
AXGN | 44.65% | $561.11M | +113.93% | 0.00% |
BCO | 41.69% | $4.00B | +19.00% | 1.04% |
JBI | 41.45% | $1.00B | -31.76% | 0.00% |
PLNT | 40.67% | $8.24B | +51.10% | 0.00% |
TRN | 40.07% | $3.12B | +54.58% | 2.95% |
CTMX | 40.05% | $69.86M | -31.59% | 0.00% |
BMRN | 39.52% | $11.81B | -29.63% | 0.00% |
FOR | 39.08% | $1.48B | -8.19% | 0.00% |
RXST | 37.21% | $1.82B | +62.89% | 0.00% |
MBIN | 36.93% | $1.78B | +16.49% | 0.90% |
OLO | 36.35% | $1.06B | +30.00% | 0.00% |
CRSP | 36.34% | $4.01B | -30.49% | 0.00% |
KNSA | 35.54% | $1.50B | +30.78% | 0.00% |
NEO | 35.00% | $1.97B | -19.92% | 0.00% |
SGRY | 34.98% | $2.89B | -28.97% | 0.00% |
DOCN | 34.97% | $3.51B | +33.83% | 0.00% |
RDNT | 34.86% | $5.91B | +151.89% | 0.00% |
NTLA | 34.81% | $1.44B | -50.35% | 0.00% |
CROX | 34.74% | $5.71B | +5.81% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AGX | <0.01% | $2.01B | +224.91% | 0.85% |
AGCO | 0.03% | $6.85B | -18.68% | 1.26% |
JBSS | -0.04% | $949.98M | -9.36% | 1.04% |
GPRE | 0.05% | $682.07M | -57.68% | 0.00% |
APA | 0.06% | $8.11B | -40.14% | 4.54% |
CRK | 0.06% | $4.10B | +33.84% | 0.88% |
ARCH | -0.06% | $3.03B | +7.87% | 1.26% |
CASI | 0.07% | $71.56M | -6.32% | 0.00% |
CRVO | 0.08% | $83.20M | +2.86% | 0.00% |
TR | -0.10% | $2.33B | -0.74% | 1.10% |
EH | 0.13% | $689.36M | +1.82% | 0.00% |
HIG | -0.14% | $33.87B | +51.09% | 1.60% |
WEC | -0.16% | $31.33B | +22.40% | 3.38% |
RTX | 0.17% | $158.34B | +52.22% | 2.09% |
AJG | -0.21% | $64.17B | +17.51% | 0.80% |
MCS | 0.22% | $669.85M | +49.35% | 1.28% |
BTU | 0.23% | $3.23B | +14.05% | 1.13% |
OHI | 0.24% | $10.84B | +26.02% | 6.71% |
VPG | 0.25% | $279.20M | -30.23% | 0.00% |
MTDR | -0.26% | $7.21B | -1.21% | 1.47% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ALTO | -40.69% | $106.54M | -39.83% | 0.00% |
VTYX | -24.81% | $125.87M | -23.61% | 0.00% |
OPRT | -19.90% | $112.95M | +40.81% | 0.00% |
ADTN | -19.65% | $627.65M | +47.76% | 0.00% |
TPST | -17.47% | $37.75M | -77.59% | 0.00% |
NOC | -16.38% | $71.54B | +4.23% | 1.60% |
NINE | -16.26% | $49.99M | -42.44% | 0.00% |
APD | -16.20% | $72.92B | +18.69% | 2.14% |
CBOE | -16.18% | $21.46B | +15.84% | 1.11% |
LEG | -16.04% | $1.54B | -50.75% | 9.00% |
EXEL | -15.46% | $9.83B | +62.16% | 0.00% |
VFC | -15.40% | $7.51B | +16.70% | 1.89% |
COR | -15.28% | $47.48B | +21.20% | 0.86% |
ATSG | -14.66% | $1.44B | +39.23% | 0.00% |
TCMD | -14.26% | $378.43M | +24.66% | 0.00% |
GIS | -13.89% | $34.85B | -2.91% | 3.78% |
CVS | -13.37% | $70.18B | -18.08% | 4.72% |
CYCN | -12.54% | $4.77M | -16.19% | 0.00% |
GPRK | -12.13% | $440.00M | -9.95% | 6.37% |
CME | -12.07% | $82.76B | +9.21% | 1.98% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XHE | 42.83% | $213.41M | 0.35% |
QQA | 40.62% | $135.01M | 0% |
PTH | 40.16% | $143.31M | 0.6% |
PFUT | 38.08% | $326.69M | 0.64% |
FFTY | 36.74% | $67.59M | 0.8% |
FNY | 36.41% | $372.31M | 0.7% |
XBI | 36.32% | $6.58B | 0.35% |
ICVT | 35.96% | $2.44B | 0.2% |
IWP | 35.80% | $17.19B | 0.23% |
IHAK | 35.76% | $916.89M | 0.47% |
VBK | 35.54% | $19.31B | 0.07% |
IWO | 35.51% | $12.56B | 0.24% |
ARKG | 35.45% | $1.13B | 0.75% |
ISCG | 35.28% | $640.00M | 0.06% |
IMCG | 34.86% | $2.42B | 0.06% |
VXF | 34.81% | $21.54B | 0.06% |
GNOM | 34.65% | $70.59M | 0.5% |
VOT | 34.40% | $15.26B | 0.07% |
CWB | 34.25% | $3.94B | 0.4% |
QLTY | 34.24% | $1.28B | 0.5% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FCG | 0.07% | $395.85M | 0.6% |
BILZ | 0.10% | $563.02M | 0.14% |
DBMF | 0.33% | $1.02B | 0.85% |
GBIL | 0.40% | $5.60B | 0.12% |
CANE | -0.48% | $17.72M | 0.29% |
CMDY | 0.59% | $279.14M | 0.28% |
PXJ | -0.66% | $42.76M | 0.66% |
HIGH | -0.73% | $302.78M | 0.51% |
XOP | 0.77% | $2.58B | 0.35% |
WEAT | 0.79% | $120.27M | 0.28% |
KCCA | 0.85% | $220.51M | 0.87% |
BCD | -0.87% | $245.02M | 0.3% |
DUSB | -0.97% | $797.63M | 0.15% |
OIH | 0.99% | $1.69B | 0.35% |
XBIL | 1.13% | $637.70M | 0.15% |
BCI | -1.19% | $1.20B | 0.26% |
FXN | 1.20% | $416.11M | 0.62% |
TPMN | -1.22% | $40.60M | 0.65% |
IYK | -1.40% | $1.30B | 0.4% |
TBIL | 1.45% | $4.38B | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -32.87% | $388.04M | 1.43% |
VIXY | -19.94% | $195.31M | 0.85% |
TAIL | -17.59% | $67.98M | 0.59% |
USDU | -16.02% | $201.97M | 0.5% |
DBA | -15.58% | $755.88M | 0.93% |
UUP | -12.74% | $309.25M | 0.77% |
CCOR | -10.76% | $109.04M | 1.18% |
USCI | -8.94% | $185.47M | 1.07% |
DBE | -8.75% | $50.13M | 0.77% |
DBO | -8.23% | $217.57M | 0.77% |
COMT | -8.17% | $829.06M | 0.48% |
CTA | -7.86% | $350.27M | 0.78% |
GSG | -7.64% | $914.42M | 0.75% |
FTSD | -6.88% | $171.68M | 0.25% |
IBDP | -6.14% | $2.11B | 0.1% |
FMF | -5.55% | $244.61M | 0.95% |
ULST | -5.03% | $535.47M | 0.2% |
FTSM | -4.89% | $6.08B | 0.45% |
PDBC | -4.84% | $4.40B | 0.59% |
BSCO | -4.54% | $2.35B | 0.1% |
Yahoo
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a fireside chat at the upcoming Piper Sandler 36th Annual Healthcare Conference at the Lotte New York Palace. The fireside chat will take place on Tuesday, December 3, 2024, at 4:00 p.m. Eastern Time.
SeekingAlpha
TransMedics' Q3 earnings report led to a huge drop, which was completely unjustified. Click here to read an analysis of TMDX stock now.
Yahoo
This organ transplant specialist is down, but still has plenty of signs of life.
SeekingAlpha
TransMedics' Q3 results were weak, but long-term growth opportunities remain. Learn why TMDX stock is a compelling buy despite short-term challenges.
SeekingAlpha
RVT primarily invests in the small-cap space and invests in companies that have strong fundamentals. Find out my recommendation for the fund.
Yahoo
Sales growth is tapering off for this provider of delivery services for transplant organs.
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.